Email this article Efficiency of application of metformin and its combination with combined oral ontrceptive, containing drospirenone, in women with polycystic ovary syndrome
- Authors: Soboleva Y.L.1
-
Affiliations:
- D. O. Ott Research Institute of Obstetrics and Gynecology, RAMS
- Issue: Vol 62, No 4 (2013)
- Pages: 55-60
- Section: Articles
- URL: https://journals.rcsi.science/jowd/article/view/2607
- DOI: https://doi.org/10.17816/JOWD62455-60
- ID: 2607
Cite item
Full Text
Abstract
The article represents results of monotherapy with metformin, as well as combined treatment with metformin and combined oral contraceptive (COC), containing drospirenone, in patients with polycystic ovary syndrome (PCOS). In general, treatment was given to 42 patients with PCOS. Combined treatment was prescribed to 18 of them. Equally high efficiency of both schemes of treatment in correction of disorders of carbohydrate metabolism was demonstrated. But efficacy of metformin alone in restoration of ovulatory menstrual cycle was low – ovulation occurred in 3 patients (13 %) and only two women (8.7 %)became pregnant. These results do not allow recommendation of monotherapy with this medication for restoration of fertility. Implication of combined therapy has shown benefits in normalization of menstrual cycle, ultrasound structure and volume of ovaries. COC with drospirenone also has antiandrogenic properties. So combination of metformin with COC, containing drospirenone, can be recommended as a first-line therapeutic option for patients with PCOS and impaired carbohydrate metabolism.
Full Text
##article.viewOnOriginalSite##About the authors
Yelena Leonidovna Soboleva
D. O. Ott Research Institute of Obstetrics and Gynecology, RAMS
Email: doclena@inbox.ru
MD, Senior research associate, Reproductive Endocrinology Department
References
- Геворкян М. А. Эндокринно-метаболические и молекулярно-биологические факторы в восстановлении репродуктивного здоровья у женщин с синдромом поликистозных яичников: автореф. дис… д-ра. мед. наук. — М., 2001.
- Распространенность и клиническая картина синдрома поликистозных яичников в популяции Москвы / И. И. Дедов [и др.] // Проблемы эндокринологии. — 2010. — Т. 56, № 4. — С. 3–8.
- Чеботникова Т. В., Мельниченко Г. А. Перименопауза при СПКЯ // Проблемы репродукции. — 2007. — № 3. — С. 50–56.
- Шевцова В. Л. Клиническое значение эндокринно-метаболических нарушенией при синдроме поликистозных яичников и оптимизация методов их терапии: автореф. дис… канд. мед. наук. — М., 2006. — 23 с.
- Characteristics of glucose metabolism in non-obese and obese women withpolycystic ovarian syndrome / Y. H. Shi [et al.] // Zhonghua Fu Chan Ke Za Zhi. — 2010. — Vol. 45, N 8. — P. 575–577.
- Correlation of hyperandrogenism with hyperinsulinemia in PCOD / G. A. Burghen [et al.] // J. Clin. Endocrinol. Metab. — 1980. — Vol. 50. — P. 113–115.
- Glucose intolerance in polycystic ovary syndrome — a position statement of the Androgen Excess Society / K. E. Salley [et al.] // J. Clin. Endocrinol. Metab. — 2007. — Vol. 92, N 12. — P. 4546–4556.
- Kazerooni T., Dehghan-Kooshkghazi M. Effects of metformin therapy on hyperandrogenism in women with polycystic ovary syndrome // Gynecol. Endocrinol. — 2003. — Vol. 17, N 1. — P. 51–56.
- Lord J. M., Flight I. H., Norman R. J. Metformin in polycystic ovary syndrome: systematic review and meta-analysis // BMJ. — 2003. — Vol. 327, N 7421. — P. 951–953.
- Metformin therapy improves the menstrual pattern with minimal endocrine and metabolic effects in women with polycystic ovary syndrome / L. C. Morin-Papunen [et al.] // Fertil. Steril. — 1998. — Vol. 69, N 4. — P. 691–696.
- Metformin-induced resumption of normal menses in 39 of 43 (91 %) previously amenorrheic women with the polycystic ovary syndrome / C. J. Glueck [et al.] // Metabolism. — 1999. — Vol. 48, N 4. — P. 511–519.
- Metformin effects on clinical features, endocrine and metabolic profiles, and insulin sensitivity in polycystic ovary syndrome: a randomized, double-blind, placebo-controlled 6-month trial, followed by open, long-term clinical evaluation / P. Moghetti [et al.] // J. Clin. Endocrinol. Metab. — 2002. — Vol. 85, N 1. — P. 139–146.
- Metformin versus oral contraceptive pill in polycystic ovary syndrome: a Cochrane review / M. Costello [et al.] // Hum. Reprod. — 2007. — Vol. 22, N 5. — P. 1200–1209.
- Мetformin and glitazones: do they really help PCOS patients / A. Pillai [et al.] // Fam. Pract. — 2007. — Vol. 56, N 6. — P. 444–453.
- Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women / R. S. Legro [et al.] // J. Clin. Endocrino. l. Metab. — 1999. — Vol. 84, N 1. — P. 165–169.
- Prevalence of impaired glucose tolerance and diabetes in women with polycysticovary syndrome / D. A. Ehrmann [et al.] // Diabetes Care. — 1999. — Vol. 22. — P. 141–146.
- Rotterdam ESHRE/ASRM-Sponsored Consensus Workshop Group 2004. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome // Hum. Reprod. — 2004. — Vol. 19, N1. — P. 41–47.
